Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

PSMD14 increases the amount of ERBB2. 2 / 2

| 2

➶

reach

"POH1 can elevate ErbB2 levels by counteracting receptor ubiquitination that occurs following activating signals from growth factors."

22819849

➶

reach

"POH1 has also been shown to modulate the expression of ErbB2, a receptor tyrosine kinase whose over-expression is correlated with poor prognosis in breast cancer (Liu et al., 2009)."

22819849

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...